Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
10.9%
% of CANC's 46 holdings also in XDNA
21.7%
% of XDNA's 23 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
 |
INTELLIA THERAPEUTICS, INC. | 2.9% | 8.7% | 2.9% |
 |
NOVARTIS AG | 2.4% | 3.0% | 2.4% |
|
CRISPR THERAPEUTICS AG | 2.1% | 15.1% | 2.1% |
|
REGENERON PHARMACEUTICALS | 5.6% | 1.3% | 1.3% |
|
ILLUMINA INC | 2.9% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to XDNA
 |
ASTRAZENECA PLC | 5.2% |
|
MERCK & CO. INC. | 4.4% |
|
REGENERON PHARMACEUTICALS | 4.4% |
 |
ARGENX SE ADR | 3.9% |
 |
DAIICHI SANKYO CO LTD | 3.9% |
|
REVOLUTION MEDICINES, INC. | 3.5% |
|
AMGEN INC | 3.4% |
|
BLUEPRINT MEDICINES CORP. | 3.3% |
|
EXELIXIS INC | 3.3% |
|
INCYTE CORP | 3.2% |
CANC Underweight Relative to XDNA
|
BEAM THERAPEUTICS, INC. | -13.7% |
|
CRISPR THERAPEUTICS AG | -13.1% |
|
THERMO FISHER SCIENTIFIC INC | -9.5% |
|
PRIME MEDICINE, INC. | -5.9% |
|
INTELLIA THERAPEUTICS, INC. | -5.8% |
|
EDITAS MEDICINE, INC. | -5.7% |
|
CARIBOU BIOSCIENCES, INC. | -4.7% |
|
VERVE THERAPEUTICS, INC. | -4.5% |
|
POSEIDA THERAPEUTICS, INC. | -4.1% |
|
ABBVIE INC | -3.8% |